News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Robert Huisden

Articles by Robert Huisden

4 Datopotamab Deruxtecan (Dato-DXd) + Durvalumab (D) as First-Line (1L) Treatment for Unresectable Locally Advanced/ Metastatic Triple-Negative Breast Cancer (a/mTNBC): Updated Results From BEGONIA, a Phase 1b/2 Study

ByJamil Asselah,Cynthia X. Ma, MD, PhD,Zbigniew Nowecki,Robert Huisden,Ross Stewart,Petra Vuković,Peter Schmid, MD

April 28th 2023

Latest Updated Articles

Trending on CancerNetwork

Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer

What Role Will The EV-304 Regimen Occupy in The Bladder Cancer Paradigm?

Impact of IGNYTE Trial Responses to RP1/Nivolumab in Advanced Melanoma

Accounting for Operative Variables in HIFU For Localized Prostate Cancer

How Might a Novel Radioenhancer Impact Stage III Unresectable NSCLC Care?